October is more than pink ribbons—it’s practical steps. This year brings real updates: a new federal “dense breast” notification you’ll see in your mammogram letter, finalized screening guidance to start at age 40, and smarter imaging tools that cut down on false alarms. Here’s what changed, why it matters, and exactly what to do this week.
SportPort Active was founded to champion women’s breast health in motion. Since 2011, we’ve pioneered patented sports bras with a built‑in, EMF‑shielding phone pocket —designed to keep your essentials secure and your device discreetly stowed so you can move with comfort and confidence.
This Breast Cancer Awareness Month, we’re pairing that same commitment to smart design with the latest, need‑to‑know guidance on your screening plan.

What changed—and why it matters
-
Mammograms now start at age 40 (every other year to 74) for average‑risk women. In April 2024, the U.S. Preventive Services Task Force (USPSTF) made this a final Grade‑B recommendation. Translation: strong evidence of benefit and broad insurance coverage under preventive care.
-
Many expert groups align—but differ on frequency. The CDC echoes the USPSTF (biennial 40–74), while radiology and ob‑gyn groups (ACR, ACOG) support annual screening starting at 40 based on shared decision‑making. Use your risk profile (family history, genetics, density) to choose annual vs. biennial.
-
Why the shift earlier? Breast cancer incidence has crept up among women in their 40s; ACS reports rising trends and projects 316,950 new invasive cases in U.S. women in 2025.
The letter you’ll see after your mammogram just changed
As of September 10, 2024, U.S. mammography centers must include standardized language telling you whether your breasts are “dense” or “not dense.” This is now federal law under the Mammography Quality Standards Act (MQSA) . Read that section carefully—it guides your next step. If your letter says “not dense”:
-
Stay on your age‑appropriate mammogram schedule (40–74 for average risk). Digital breast tomosynthesis (DBT, often called 3D) is widely used and may reduce false‑positive callbacks compared with standard 2D. Ask your center if they use DBT.
If your letter says “dense”:
-
Don’t panic—about half of women over 40 have dense breasts. Density is common and normal; it can slightly raise risk and make cancers harder to see on mammograms. Your letter is your prompt to discuss supplemental screening and personal risk.
-
The USPSTF says evidence is insufficient to recommend supplemental ultrasound or MRI for all women with dense breasts. But ACR/NCCN recommend MRI for women with ≥20% lifetime risk (often calculated via tools like Tyrer‑Cuzick), and they support DBT for most. This is where personalized care matters.
Smarter tech you’ll hear about (and why it helps)
-
DBT (3D mammography) tends to lower recall rates and increase cancer detection vs. traditional 2D in observational cohorts, with similar interval cancer rates. Many U.S. centers have already adopted it.
-
AI‑assisted reading is beginning to reduce workload without sacrificing detection in large European trials (e.g., MASAI and ScreenTrustCAD). You might not notice it, but your images could be read faster with fewer unnecessary callbacks.
Your 15‑minute, do‑it‑this‑week screening plan
-
Book (or re‑book) your mammogram if you’re 40–74 and due. Ask if your center uses DBT.
-
Bring your density letter to your visit. If dense, ask:
-
“Am I average or increased risk?”
-
“Do I qualify for MRI (≥20% lifetime risk) or other supplemental tests?” (MRI is typically considered at ≥20% lifetime risk.)
-
Know the cadence: Biennial is the USPSTF default, but discuss annual screening if you prefer or if your risk profile suggests it (ACR/ACOG often favor annual).
-
Set reminders in your calendar for next year (or in 2 years).
-
Share this post with your walking group, PTA chat, or sister—screening saves lives.

FAQ—fast answers you’ll actually use
“I’m 42 and busy—can I skip a year?”
The USPSTF recommends every other year; ACR/ACOG often support annual. If you have dense breasts or a family history, an annual schedule may be a better fit—align with your clinician.
“My letter says ‘dense’—do I automatically need an MRI?”
Not automatically. Density alone doesn’t trigger MRI for everyone. MRI is typically for women at ≥20% lifetime risk. Your clinician can calculate this and discuss options (DBT, MRI, sometimes ultrasound).
“Do new tools really reduce false alarms?”
Many programs using DBT show lower recall compared with 2D, and early AI research suggests similar detection with less workload. Fewer callbacks = fewer unnecessary second appointments for you.
The SportPort Active POV—support for your screening day
On mammogram day, you want easy on/off layers and a supportive, no‑drama sports bra for your post‑appointment walk. We design medium and high‑support encapsulation styles with our patented EMF‑shielding phone pocket so you can stash your phone and de‑stress with a few laps around the block.
Bottom line: If you’re 40+, get on the books. Read your density letter. Choose a cadence that matches your risk and your life. That’s the 2025 reset.

Breast Cancer Facts and Stats
Cancer.org/Cancer Facts and Statistics
National Breast Cancer Foundation/About Breast Cancer
National Breast Cancer.org/What is BRCA?
American Cancer Research/Breast Cancer Awareness Month
World Health Organization/Breast Cancer Awareness Month 2025